Back
Liquidia Vs. United Therapeutics Industry Stock Comparison
Buy
56
LQDA
Liquidia
Last Price:
10.11
Seasonality Move:
33.55%
Sell
50
UTHR
United Therapeutics
Last Price:
364.59
Seasonality Move:
10.82%
Buy
56
Liquidia (LQDA)
is a Buy
Is Liquidia a Buy, Sell or Hold?
- The current Liquidia [LQDA] share price is $10.12. The Score for LQDA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LQDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $364.33. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LQDA Stock Price Chart
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $364.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LQDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 41.36 | Sell |
| Chaikin Money Flow: | -63283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.27 - 11.19) | Sell |
| Bollinger Bands (100): | (9.75 - 11.95) | Sell |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | 110184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (355.36 - 392.44) | Sell |
| Bollinger Bands (100): | (327.49 - 369.99) | Buy |
LQDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.2 | Sell |
| 20-day SMA: | 10.6 | Sell |
| 50-day SMA: | 10.53 | Sell |
| 200-day SMA: | 12.33 | Sell |
| 8-day EMA: | 10.2 | Sell |
| 20-day EMA: | 10.46 | Sell |
| 50-day EMA: | 10.62 | Sell |
| 200-day EMA: | 11.08 | Sell |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 379.48 | Sell |
| 20-day SMA: | 375.79 | Sell |
| 50-day SMA: | 363.31 | Buy |
| 200-day SMA: | 300.12 | Buy |
| 8-day EMA: | 373.36 | Sell |
| 20-day EMA: | 374.93 | Sell |
| 50-day EMA: | 364.61 | Sell |
| 200-day EMA: | 314.85 | Buy |
Liquidia Earnings Growth & LQDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and an increase next year of $0.37 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Liquidia Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||